Taipei City | Date: September, 2024
YC Biotech CO., LTD. is excited to announce its official collaboration with Sentronic International Corp. to launch the clinical trial for the G-BeBiteĀ® Dental Implant System. This groundbreaking project, commissioned by Sentronic International Corp., designates YC Biotech as the contracted research organization (CRO), responsible for designing, planning, and executing the trial. The study aims to assess the clinical safety and efficacy of the implant system, ensure the feasibility of patient recruitment and trial execution, and explore expanded applications for dental implant technologies.
The G-BeBiteĀ® Dental Implant System represents a state-of-the-art advancement, combining innovative design with optimized materials to improve dental implant treatment outcomes. It offers enhanced therapeutic options for edentulous patients, aiming to improve their quality of life while driving progress in the field of dentistry. This collaboration underscores both companies’ shared commitment to innovation and highlights YC Biotech ‘s expertise in clinical trial management and data analysis.
YC Biotech views this collaboration as a critical milestone in the development and commercialization of next-generation dental solutions. Looking ahead, YC Biotech remains committed to driving medical innovation through clinical application and technology commercialization, contributing to improved healthcare outcomes for patients in the future.
For the latest updates on this collaboration and other initiatives, please visit YC Biotech ‘s official website.
